Company / Working Capital per Share
Acadia Pharmaceuticals Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$4.71
FY2025
5-year range
$2.23 / $4.71
FY2021-FY2025
Trend
+42.7%
vs FY2024
Sector context
#112 of 210
Health Care
What the data says
At $4.71, Acadia Pharmaceuticals's working capital per share ranks #112 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $2.23 in FY2023 to $4.96 in FY2016.
Based on SEC 10-K filings.
4.71 in FY2025 with a 5-year CAGR of +3.6%.
Improved from $2.23 to $4.71 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +25.6%
- 5-Year CAGR
- +3.6%
- 10-Year CAGR
- -
Sector benchmark
#112 of 210 in Health CareTop 53% of 210This company $4.71 Sector average $118.60
▼
-96.0% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 42.7% year-over-year.
- Ranks #112 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2016.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.71 | +42.7% |
| FY2024 | $3.30 | +47.8% |
| FY2023 | $2.23 | -6.0% |
| FY2022 | $2.37 | -27.4% |
| FY2021 | $3.27 | -17.0% |
| FY2020 | $3.94 | -17.3% |
| FY2019 | $4.76 | +27.1% |
| FY2018 | $3.75 | +40.3% |
| FY2017 | $2.67 | -46.1% |
| FY2016 | $4.96 | +151.6% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026